mTOR hyperactivation in Down Syndrome underlies deficits in autophagy induction, autophagosome formation, and mitophagy
暂无分享,去创建一个
R. Nixon | M. Mellén | M. Bordi | Ying Jiang | M. Berg | Yutaka Sato | Asok Kumar | Sandipkumar Darji | Y. Sato
[1] Mark R. Marten,et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 , 2021, Autophagy.
[2] A. Cuervo,et al. Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99) , 2019, The Journal of Neuroscience.
[3] R. Youle,et al. Mitophagy and Quality Control Mechanisms in Mitochondrial Maintenance , 2018, Current Biology.
[4] T. Burgoyne,et al. Oxidation of Atg3 and Atg7 mediates inhibition of autophagy , 2018, Nature Communications.
[5] A. Ballabio,et al. Molecular definitions of autophagy and related processes , 2017, The EMBO journal.
[6] G. Qin,et al. FoxO1 Promotes Mitophagy in the Podocytes of Diabetic Male Mice via the PINK1/Parkin Pathway , 2017, Endocrinology.
[7] D. Hwang,et al. Characterization of developmental defects in the forebrain resulting from hyperactivated mTOR signaling by integrative analysis of transcriptomic and proteomic data , 2017, Scientific Reports.
[8] S. Ginsberg,et al. Autophagy flux in CA1 neurons of Alzheimer hippocampus: Increased induction overburdens failing lysosomes to propel neuritic dystrophy , 2016, Autophagy.
[9] L. Scorrano,et al. Mitochondrial Cristae: Where Beauty Meets Functionality. , 2016, Trends in biochemical sciences.
[10] V. Shoshan-Barmatz,et al. The mitochondrial voltage-dependent anion channel 1 in tumor cells. , 2015, Biochimica et biophysica acta.
[11] N. Mizushima,et al. Autophagy machinery in the context of mammalian mitophagy. , 2015, Biochimica et biophysica acta.
[12] R. Nixon,et al. Presenilin 1 Maintains Lysosomal Ca(2+) Homeostasis via TRPML1 by Regulating vATPase-Mediated Lysosome Acidification. , 2015, Cell reports.
[13] J. Burman,et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy , 2015, Nature.
[14] R. Youle,et al. MiT/TFE transcription factors are activated during mitophagy downstream of Parkin and Atg5 , 2015, The Journal of cell biology.
[15] M. Carrillo,et al. Down syndrome and Alzheimer's disease: Common pathways, common goals , 2015, Alzheimer's & Dementia.
[16] A. Goldberg,et al. Regulation of autophagy and the ubiquitin–proteasome system by the FoxO transcriptional network during muscle atrophy , 2015, Nature Communications.
[17] R. Youle,et al. The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease , 2015, Neuron.
[18] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[19] E. Holzbaur,et al. Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation , 2014, Proceedings of the National Academy of Sciences.
[20] P. Deyn,et al. Epigenetics: The neglected key to minimize learning and memory deficits in Down syndrome , 2014, Neuroscience & Biobehavioral Reviews.
[21] Haitao Wang,et al. The Nerve Growth Factor Signaling and Its Potential as Therapeutic Target for Glaucoma , 2014, BioMed research international.
[22] E. Aronica,et al. mTOR Hyperactivation in down syndrome hippocampus appears early during development. , 2014, Journal of neuropathology and experimental neurology.
[23] D. Butterfield,et al. Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain. , 2014, Biochimica et biophysica acta.
[24] D. Sabatini,et al. Regulation of mTORC1 by amino acids. , 2014, Trends in cell biology.
[25] A. Whitworth,et al. Genome-wide RNAi screen identifies the Parkinson disease GWAS risk locus SREBF1 as a regulator of mitophagy , 2014, Proceedings of the National Academy of Sciences.
[26] Longxuan Li,et al. ULK1 translocates to mitochondria and phosphorylates FUNDC1 to regulate mitophagy , 2014, EMBO reports.
[27] T. Hirokawa,et al. Ubiquitin is phosphorylated by PINK1 to activate parkin , 2014, Nature.
[28] Stylianos E. Antonarakis,et al. Domains of genome-wide gene expression dysregulation in Down’s syndrome , 2014, Nature.
[29] D. Graves,et al. FOXO Transcription Factors: Their Clinical Significance and Regulation , 2014, BioMed research international.
[30] Michael N. Hall,et al. Making new contacts: the mTOR network in metabolism and signalling crosstalk , 2014, Nature Reviews Molecular Cell Biology.
[31] A. Schapira,et al. Mitochondrial impairment increases FL-PINK1 levels by calcium-dependent gene expression , 2014, Neurobiology of Disease.
[32] J. Martina,et al. Novel roles for the MiTF/TFE family of transcription factors in organelle biogenesis, nutrient sensing, and energy homeostasis , 2014, Cellular and Molecular Life Sciences.
[33] D. Klionsky,et al. The machinery of macroautophagy , 2013, Cell Research.
[34] T. Yoshimori,et al. The autophagosome: origins unknown, biogenesis complex , 2013, Nature Reviews Molecular Cell Biology.
[35] S. Melov,et al. SOD2 in mitochondrial dysfunction and neurodegeneration. , 2013, Free radical biology & medicine.
[36] R. Nixon,et al. The role of autophagy in neurodegenerative disease , 2013, Nature Medicine.
[37] P. Boya,et al. Emerging regulation and functions of autophagy , 2013, Nature Cell Biology.
[38] Alexander M van der Bliek,et al. Mechanisms of mitochondrial fission and fusion. , 2013, Cold Spring Harbor perspectives in biology.
[39] C. Chu,et al. After the banquet , 2013, Autophagy.
[40] D. Sabatini,et al. Regulation of mTORC1 and its impact on gene expression at a glance , 2013, Journal of Cell Science.
[41] S. Benkovic,et al. Replication clamps and clamp loaders. , 2013, Cold Spring Harbor perspectives in biology.
[42] Mauro Piacentini,et al. mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6 , 2013, Nature Cell Biology.
[43] M. Ripoli,et al. Chronic pro-oxidative state and mitochondrial dysfunctions are more pronounced in fibroblasts from Down syndrome foeti with congenital heart defects. , 2013, Human molecular genetics.
[44] G. Helguera,et al. Adaptive downregulation of mitochondrial function in down syndrome. , 2013, Cell metabolism.
[45] D. Krainc,et al. Phosphatase and Tensin Homolog (PTEN)-induced Putative Kinase 1 (PINK1)-dependent Ubiquitination of Endogenous Parkin Attenuates Mitophagy , 2012, The Journal of Biological Chemistry.
[46] T. Schwarz,et al. The pathways of mitophagy for quality control and clearance of mitochondria , 2012, Cell Death and Differentiation.
[47] D. Sabatini,et al. mTOR Signaling in Growth Control and Disease , 2012, Cell.
[48] N. Mizushima,et al. Structures containing Atg9A and the ULK1 complex independently target depolarized mitochondria at initial stages of Parkin-mediated mitophagy , 2012, Journal of Cell Science.
[49] A. Ballabio,et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB , 2012, The EMBO journal.
[50] M. Hall,et al. Rapamycin passes the torch: a new generation of mTOR inhibitors , 2011, Nature Reviews Drug Discovery.
[51] M. L. Montesinos,et al. An Increase in Basal BDNF Provokes Hyperactivation of the Akt-Mammalian Target of Rapamycin Pathway and Deregulation of Local Dendritic Translation in a Mouse Model of Down's Syndrome , 2011, The Journal of Neuroscience.
[52] Andrea Ballabio,et al. TFEB Links Autophagy to Lysosomal Biogenesis , 2011, Science.
[53] S. Lipton,et al. Oxidation of the cysteine-rich regions of parkin perturbs its E3 ligase activity and contributes to protein aggregation , 2011, Molecular Neurodegeneration.
[54] David S. Park,et al. Parkin is transcriptionally regulated by ATF4: evidence for an interconnection between mitochondrial stress and ER stress , 2011, Cell Death and Differentiation.
[55] E. Marra,et al. Deficit of complex I activity in human skin fibroblasts with chromosome 21 trisomy and overproduction of reactive oxygen species by mitochondria: involvement of the cAMP/PKA signalling pathway. , 2011, The Biochemical journal.
[56] V. Orlando,et al. The DNA repair complex Ku70/86 modulates Apaf1 expression upon DNA damage , 2011, Cell Death and Differentiation.
[57] B. Viollet,et al. Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy , 2011, Science.
[58] D. Sabatini,et al. mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.
[59] Di Wu,et al. ROAST: rotation gene set tests for complex microarray experiments , 2010, Bioinform..
[60] Wei-Guo Zhu,et al. Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity , 2010, Nature Cell Biology.
[61] T. Mak,et al. FOXO3a-dependent regulation of Pink1 (Park6) mediates survival signaling in response to cytokine deprivation , 2009, Proceedings of the National Academy of Sciences.
[62] M. LaVoie,et al. The effects of oxidative stress on parkin and other E3 ligases , 2007, Journal of neurochemistry.
[63] K. Yamakawa,et al. Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome. , 2006, Human molecular genetics.
[64] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[65] R. Scarpulla,et al. Control of Mitochondrial Transcription Specificity Factors (TFB1M and TFB2M) by Nuclear Respiratory Factors (NRF-1 and NRF-2) and PGC-1 Family Coactivators , 2005, Molecular and Cellular Biology.
[66] Caine W. Wong,et al. Altered Metabolism of the Amyloid β Precursor Protein Is Associated with Mitochondrial Dysfunction in Down's Syndrome , 2002, Neuron.
[67] M. Hattori,et al. The DNA sequence of human chromosome 21 , 2000, Nature.
[68] B. Yankner,et al. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro , 1995, Nature.
[69] E. Head,et al. mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease‐like dementia , 2018, Free radical biology & medicine.
[70] Lee,et al. Editorial :Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). DOI: 10.1080/15548627.2015.1100356;WOS:000373595400001; 2-s2.0-85013763791&;PMID: 26799652 , 2016 .
[71] F. Pallardó,et al. Decreased cell proliferation and higher oxidative stress in fibroblasts from Down Syndrome fetuses. Preliminary study. , 2014, Biochimica et biophysica acta.
[72] R. Hosking. mTOR: The Master Regulator , 2012, Cell.
[73] Lisa L. Smith,et al. AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. , 2010, Cancer research.